This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Cesarean Section; Complications, Woun...

Patient Reported Experiences and Outcomes Associated with Standard C-Section Wound Closure Versus STRATAFIX/DERMABOND PRINEO Wound Closure (CS-PREO)

Sponsored by North York General Hospital

About this trial

Last updated 8 months ago

Study ID

0434

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18+ Years
Female
Female

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 9 months ago

What is this trial about?

The aim of the study is to compare outcomes between patients receiving standard C-section wound closure compared to a wound closure bundle that includes Stratafix sutures and Dermabond PRINEO.

What are the participation requirements?

Yes

Inclusion Criteria

1. Patient must be 18 years of age or older at time of recruitment

2. Patients opting for a planned (elective) C-Section (13-36 weeks gestation) will be eligible to consent.

3. Patients must have internet access and/or a smartphone in order to access the digital platform to complete the study questionnaires

4. Patients must speak and write in English as study questionnaires will only be provided in English

5. Patients must have coverage from the Ontario Health Insurance Plan (OHIP)

No

Exclusion Criteria

1. Patients assessed by the participating surgeon with any conditions that may compromise their:

- Ability to consent or use the virtual care platform (e.g., patients with intellectual disabilities)
- Expectation of significant maternal complications that may affect the surgery

2. Patients who enroll in the study but have an unplanned emergency C-section

Locations

Location

Status

Recruiting